Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Feb 23. doi: 10.1002/mds.27311. [Epub ahead of print]

PMID:
29473691
2.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Jan 30. doi: 10.1002/mds.27282. [Epub ahead of print]

PMID:
29380907
3.

Reply: MRI findings of visual system alterations in Parkinson's disease.

Weil RS, McColgan P, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR.

Brain. 2017 Nov 1;140(11):e70. doi: 10.1093/brain/awx245. No abstract available.

PMID:
29053804
4.

The Cats-and-Dogs test: A tool to identify visuoperceptual deficits in Parkinson's disease.

Weil RS, Pappa K, Schade RN, Schrag AE, Bahrami B, Schwarzkopf DS, Crutch SJ, O'Keeffe AG, Morris HR.

Mov Disord. 2017 Dec;32(12):1789-1790. doi: 10.1002/mds.27176. Epub 2017 Oct 4. No abstract available.

5.

Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.

Weil RS, Lashley TL, Bras J, Schrag AE, Schott JM.

F1000Res. 2017 Aug 30;6:1604. doi: 10.12688/f1000research.11725.1. eCollection 2017. Review.

6.

Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.

Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H, Kumar H, Banerjee R, Erro R, Bhidayasiri R, Schrag A, Zis P, Lim SY, Al-Hashel JY, Kamel WA, Martinez-Martin P, Ray Chaudhuri K.

Neuroepidemiology. 2017;49(1-2):1-17. doi: 10.1159/000478702. Epub 2017 Aug 12.

7.

Depression and Anxiety in Parkinson's Disease.

Schrag A, Taddei RN.

Int Rev Neurobiol. 2017;133:623-655. doi: 10.1016/bs.irn.2017.05.024. Epub 2017 Jul 21.

PMID:
28802935
8.

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G; International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW.

PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.

9.

Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.

Lane CA, Parker TD, Cash DM, Macpherson K, Donnachie E, Murray-Smith H, Barnes A, Barker S, Beasley DG, Bras J, Brown D, Burgos N, Byford M, Jorge Cardoso M, Carvalho A, Collins J, De Vita E, Dickson JC, Epie N, Espak M, Henley SMD, Hoskote C, Hutel M, Klimova J, Malone IB, Markiewicz P, Melbourne A, Modat M, Schrag A, Shah S, Sharma N, Sudre CH, Thomas DL, Wong A, Zhang H, Hardy J, Zetterberg H, Ourselin S, Crutch SJ, Kuh D, Richards M, Fox NC, Schott JM.

BMC Neurol. 2017 Apr 18;17(1):75. doi: 10.1186/s12883-017-0846-x.

10.

Viral hepatitis and Parkinson disease: A national record-linkage study.

Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M.

Neurology. 2017 Apr 25;88(17):1630-1633. doi: 10.1212/WNL.0000000000003848. Epub 2017 Mar 29.

PMID:
28356465
11.

Parkinson disease.

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE.

Nat Rev Dis Primers. 2017 Mar 23;3:17013. doi: 10.1038/nrdp.2017.13. Review.

PMID:
28332488
12.

Cognitive decline before diagnosis of Parkinson's disease - Authors' reply.

Schrag A, Weintraub D, Schott JM.

Lancet Neurol. 2017 Apr;16(4):262. doi: 10.1016/S1474-4422(17)30043-1. No abstract available.

PMID:
28327332
13.

PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.

Noyce AJ, R'Bibo L, Peress L, Bestwick JP, Adams-Carr KL, Mencacci NE, Hawkes CH, Masters JM, Wood N, Hardy J, Giovannoni G, Lees AJ, Schrag A.

Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.

14.

Subtle motor disturbances in PREDICT-PD participants.

Noyce AJ, Schrag A, Masters JM, Bestwick JP, Giovannoni G, Lees AJ.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):212-217. doi: 10.1136/jnnp-2016-314524. Epub 2016 Dec 16.

15.

Rasch analysis of the carers quality of life questionnaire for parkinsonism.

Pillas M, Selai C, Schrag A.

Mov Disord. 2017 Mar;32(3):463-466. doi: 10.1002/mds.26877. Epub 2016 Nov 22.

PMID:
27873351
16.

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM.

Lancet Neurol. 2017 Jan;16(1):66-75. doi: 10.1016/S1474-4422(16)30328-3. Epub 2016 Nov 18.

17.

Serotonergic loss underlying apathy in Parkinson's disease.

Schrag A, Politis M.

Brain. 2016 Sep;139(Pt 9):2338-9. doi: 10.1093/brain/aww190. No abstract available.

PMID:
27559106
18.

Visual dysfunction in Parkinson's disease.

Weil RS, Schrag AE, Warren JD, Crutch SJ, Lees AJ, Morris HR.

Brain. 2016 Nov 1;139(11):2827-2843. doi: 10.1093/brain/aww175. Review.

19.

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations.

Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A, Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P.

Mov Disord. 2016 Oct;31(10):1455-1465. doi: 10.1002/mds.26649. Review.

PMID:
27193358
20.

Challenges of modifying disease progression in prediagnostic Parkinson's disease.

Salat D, Noyce AJ, Schrag A, Tolosa E.

Lancet Neurol. 2016 May;15(6):637-48. doi: 10.1016/S1474-4422(16)00060-0. Epub 2016 Mar 16. Review.

PMID:
26993435
21.

Measurement instruments to assess posture, gait, and balance in Parkinson's disease: Critique and recommendations.

Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, Ruzicka E, Goetz C, Stebbins G, Martinez-Martin P, Schrag A; Movement Disorders Society Rating Scales Committee.

Mov Disord. 2016 Sep;31(9):1342-55. doi: 10.1002/mds.26572. Epub 2016 Mar 4. Review.

PMID:
26945525
22.

The prediagnostic phase of Parkinson's disease.

Noyce AJ, Lees AJ, Schrag AE.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):871-8. doi: 10.1136/jnnp-2015-311890. Epub 2016 Jan 11. Review.

23.

Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease.

Martinez-Martin P, Leentjens AF, de Pedro-Cuesta J, Chaudhuri KR, Schrag AE, Weintraub D.

Mov Disord. 2016 Mar;31(3):270-9. doi: 10.1002/mds.26522. Epub 2015 Dec 22. Review.

PMID:
26695691
24.

New clinical trials for nonmotor manifestations of Parkinson's disease.

Schrag A, Sauerbier A, Chaudhuri KR.

Mov Disord. 2015 Sep 15;30(11):1490-504. doi: 10.1002/mds.26415. Review.

PMID:
26371623
25.

Constipation preceding Parkinson's disease: a systematic review and meta-analysis.

Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):710-6. doi: 10.1136/jnnp-2015-311680. Epub 2015 Sep 7. Review.

PMID:
26345189
26.

Development and validation of a carers quality-of-life questionnaire for parkinsonism (PQoL Carers).

Pillas M, Selai C, Quinn NP, Lees A, Litvan I, Lang A, Bower J, Burn D, Low P, Schrag A.

Qual Life Res. 2016 Jan;25(1):81-8. doi: 10.1007/s11136-015-1071-y. Epub 2015 Aug 12.

PMID:
26264781
27.

A new scale for the assessment of pain in Parkinson's disease.

Schrag A.

Mov Disord. 2015 Oct;30(12):1589-90. doi: 10.1002/mds.26353. Epub 2015 Jul 31. No abstract available.

PMID:
26230748
28.

Why do patients with Parkinson's disease fall? A cross-sectional analysis of possible causes of falls.

Schrag A, Choudhury M, Kaski D, Gallagher DA.

NPJ Parkinsons Dis. 2015 Jun 11;1:15011. doi: 10.1038/npjparkd.2015.11.

29.

Web-based assessment of Parkinson's prodromal markers identifies GBA variants.

Noyce AJ, Mencacci NE, Schrag A, Bestwick JP, Giovannoni G, Lees AJ, Hardy J.

Mov Disord. 2015 Jun;30(7):1002-3. doi: 10.1002/mds.26249. Epub 2015 May 13. No abstract available.

PMID:
25970725
30.

Assessment of Parkinson's disease levodopa-induced dyskinesia: a qualitative research study.

Lenderking WR, Mannix S, Petrillo J, Kenney C, Landrian A, Schrag AE.

Qual Life Res. 2015 Aug;24(8):1899-910. doi: 10.1007/s11136-015-0925-7. Epub 2015 Feb 6.

PMID:
25655015
31.

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Schrag A, Horsfall L, Walters K, Noyce A, Petersen I.

Lancet Neurol. 2015 Jan;14(1):57-64. doi: 10.1016/S1474-4422(14)70287-X. Epub 2014 Nov 27.

32.

Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1351-7. doi: 10.5664/jcsm.4300. Review.

33.

Review of diagnostic instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.

Walters AS, Frauscher B, Allen R, Benes H, Chaudhuri KR, Garcia-Borreguero D, Lee HB, Picchietti DL, Trenkwalder C, Martinez-Martin P, Stebbins GT, Schrag A; MDS Committee on Rating Scales.

J Clin Sleep Med. 2014 Dec 15;10(12):1343-9. doi: 10.5664/jcsm.4298. Review.

34.

Imaging psychogenic movement disorders.

Mehta AR, Rowe JB, Schrag AE.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):402. doi: 10.1007/s11910-013-0402-z. Review.

35.

Genetic comorbidities in Parkinson's disease.

Nalls MA, Saad M, Noyce AJ, Keller MF, Schrag A, Bestwick JP, Traynor BJ, Gibbs JR, Hernandez DG, Cookson MR, Morris HR, Williams N, Gasser T, Heutink P, Wood N, Hardy J, Martinez M, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC).

Hum Mol Genet. 2014 Feb 1;23(3):831-41. doi: 10.1093/hmg/ddt465. Epub 2013 Sep 20.

36.

Task force report: scales for screening and evaluating tremor: critique and recommendations.

Elble R, Bain P, Forjaz MJ, Haubenberger D, Testa C, Goetz CG, Leentjens AF, Martinez-Martin P, Pavy-Le Traon A, Post B, Sampaio C, Stebbins GT, Weintraub D, Schrag A.

Mov Disord. 2013 Nov;28(13):1793-800. doi: 10.1002/mds.25648. Epub 2013 Sep 3. Review.

PMID:
24038576
37.

Impact of falls and fear of falling on health-related quality of life in patients with Parkinson's disease.

Grimbergen YA, Schrag A, Mazibrada G, Borm GF, Bloem BR.

J Parkinsons Dis. 2013 Jan 1;3(3):409-13. doi: 10.3233/JPD-120113.

PMID:
23948987
38.

Dystonia rating scales: critique and recommendations.

Albanese A, Sorbo FD, Comella C, Jinnah HA, Mink JW, Post B, Vidailhet M, Volkmann J, Warner TT, Leentjens AF, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A.

Mov Disord. 2013 Jun 15;28(7):874-83. doi: 10.1002/mds.25579. Review.

39.

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease.

Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Růžička E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A.

Mov Disord. 2014 Feb;29(2):169-76. doi: 10.1002/mds.25571. Epub 2013 Jul 16. Review.

PMID:
23861335
40.

PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, Giovannoni G, Nageshwaran S, Osborne C, Lees AJ, Schrag A.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7. doi: 10.1136/jnnp-2013-305420. Epub 2013 Jul 4.

41.

[MSA-QoL: disease-specific questionnaire to assess health-related quality of life in multiple system atrophy: validation of the German translation].

Krismer F, Duerr S, Minnerop M, Klockgether T, Stamelou M, Eggert KM, Oertel WH, Schrag A, Poewe W, Wenning GK.

Nervenarzt. 2013 Jun;84(6):709-14. doi: 10.1007/s00115-013-3764-1. German.

PMID:
23756819
42.

Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation.

Dziewulska D, Doi H, Fasano A, Erro R, Fatehi F, Fekete R, Gatto EM, Pablos EG, Lehn A, Miyajima H, Piperno A, Pellechia MT, Wu YR, Yoshida K, Zarruk JG, Jingli S, Schrag A, McNeill A.

Acta Neuropathol. 2013 Jul;126(1):151-3. doi: 10.1007/s00401-013-1136-3. Epub 2013 May 31. No abstract available.

PMID:
23722254
43.

Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease.

Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R.

Health Qual Life Outcomes. 2013 Mar 8;11:35. doi: 10.1186/1477-7525-11-35.

44.

The functional neuroimaging correlates of psychogenic versus organic dystonia.

Schrag AE, Mehta AR, Bhatia KP, Brown RJ, Frackowiak RS, Trimble MR, Ward NS, Rowe JB.

Brain. 2013 Mar;136(Pt 3):770-81. doi: 10.1093/brain/awt008.

45.

The natural history of multiple system atrophy: a prospective European cohort study.

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W; European Multiple System Atrophy Study Group.

Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5.

46.

EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M.

Eur J Neurol. 2013 Jan;20(1):16-34. doi: 10.1111/ene.12022. Review. Erratum in: Eur J Neurol. 2013 Feb;20(2):406.

PMID:
23279440
47.

Time trends in incidence of Parkinson's disease diagnosis in UK primary care.

Horsfall L, Petersen I, Walters K, Schrag A.

J Neurol. 2013 May;260(5):1351-7. doi: 10.1007/s00415-012-6804-z. Epub 2012 Dec 23.

PMID:
23263597
48.

Coactivation sign in fixed dystonia.

Mehta AR, Rowe JB, Trimble MR, Edwards MJ, Bhatia KP, Schrag AE.

Parkinsonism Relat Disord. 2013 Apr;19(4):474-6. doi: 10.1016/j.parkreldis.2012.10.014. Epub 2012 Nov 30. No abstract available.

49.

Health-related quality of life in Gilles de la Tourette syndrome: a decade of research.

Cavanna AE, David K, Bandera V, Termine C, Balottin U, Schrag A, Selai C.

Behav Neurol. 2013;27(1):83-93. doi: 10.3233/BEN-120296. Review.

50.

Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A.

Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15. Review.

Supplemental Content

Loading ...
Support Center